WHO Confirms Rare Cases of Myocarditis and Pericarditis After Pfizer and Moderna Vaccines

Pfizer and Moderna have used mRNA technology to produce their COVID vaccines. WHO has now confirmed rare cases of myocarditis and pericarditis among teens after getting these jabs.

Vaccine-related side effects like fever, muscle pain, and headache are common among all people but, more serious reactions like blood clots and inflammations in the body are dangerous. The World Health Organization has now confirmed the link between Pfizer and Moderna vaccines and rare cases of heart inflammation.

While the concerns over vaccinating children are increasing, the WHO advised clinicians to be aware of the risk of vaccine-induced myocarditis and pericarditis among adolescents.

Efficacy of Pfizer Vaccine Tested
Experts tested the efficacy of the Pfizer vaccine against SARS-CoV-2 vaccines. It showed a three-fold decrease when compared to the efficacy against the original strain.

‘Very rare cases of myocarditis and pericarditis have occurred more often in younger men, especially after the second dose of mRNA vaccines.’

Out of 177 million doses of Pfizer-BioNTech vaccines given, 145 cases of myocarditis and 138 cases of pericarditis have been reported. A total of 19 cases of myocarditis and 19 cases of pericarditis arose out of the 20 million Moderna vaccine doses given.

Myocarditis and pericarditis refer to the inflammation of the heart muscle and the heart's outer lining, respectively. The symptoms of these heart diseases include chest pain, breathing difficulties, and an increased heartbeat rate.

"Very rare cases of myocarditis and pericarditis have been observed following vaccination with the mRNA Covid-19 vaccines. These cases occurred more often in younger men and after the second dose of the vaccine, typically within a few days after vaccination. Current evidence suggests a likely causal association between myocarditis and the mRNA vaccines," highlighted WHO said in a statement.

Pfizer Vaccine 97% Effective In Symptomatic COVID-19 Cases
The COVID-19 vaccine from Pfizer-BioNtech offers at least 97% effectiveness in symptomatic coronavirus cases.

Although there is a potential link between mRNA vaccines and heart inflammation, WHO highlighted that the benefits of those vaccines still outweigh the risks. Previously the European Medicines Agency also said, "The chance of these conditions occurring is very low, but you should be aware of the symptoms so that you can get prompt medical treatment to help recovery and avoid complications."

Currently available literature suggests prompt treatment with nonsteroidal anti-inflammatory drugs following vaccination to reduce the risks of myocarditis and pericarditis.

COVID-19 Vaccines from Pfizer, Moderna Effective in Real World
In real world conditions, Pfizer-BioNTech and Moderna's COVID-19 vaccines are highly effective in preventing infections.

Source-Medindia

Miscommunication Hampers Covid-19 Vax in Southern U.S States
Texans need to have a better understanding of the time it will take for everyone to be vaccinated in order to reduce lines, confusion and frustration.